NVP-BBT594 Biochemical – Cat# MBS3610768

BBT594 (NVP-BBT594)

Name: NVP-BBT594; MyBioSource
Brand: MyBioSource
SKU: MBS3610768
Price: 265 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3610768

BBT594(NVP-BBT594) is a potent inhibitor of receptor tyrosine kinase RETTreatment of cancer. More details

$265 / 5 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

BBT594, Biochemical

Full Product Name

BBT594

Product Synonym Names

NVP-BBT594

Purity/Purification

>98% (HPLC)

Preparation and Storage

Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack

Molecular Weight

569.58

Suitability

DMSO: 33mg/mL (57.94mM)

Target

c-RET

Receptor

RET

Chemical Name

5-((6-acetamidopyrimidin-4-yl)oxy)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)indoline-1-carboxamide

SMILES

CC(=O)Nc1cc(Oc2ccc3c(c2)CCN3C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)ncn1

Molecular Formula

C28H30F3N7O3

CAS Number

882405-89-2

Product Categories/Family for BBT594 biochemical

Tyrosine Kinase

Product References and Citations for BBT594 biochemical

1.Zhang Q Shi C Han L et al. Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia [J]. Oncotarget 2018 9 (8).

Other Notes

Small volumes of BBT594 biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BBT594 purchase

MBS3610768 is a biochemical targeting BBT594.